P21 peptide
Short answer
P21 peptide, also called P021 or P-21, is a short research compound made in a lab. Mouse studies reported learning and memory findings. A rat study measured changes in tau, a brain protein. These findings do not show that P21 works or is safe in people. No P021 study in people was found. No FDA-approved U.S. P21 product was found in the records checked.
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Read the study findingsAlso known as P021 · P-21 · Peptide 021
Part of Anti-aging and longevity peptides
Legal status Is P21 peptide legal? See the status table
Study and product details
What it is
P21 peptide is a short research compound made in a lab. It is also called P021 or P-21. It is based on four amino acids from a human protein that supports some nerve cells. Amino acids are small parts that can join to make peptides and proteins. Researchers added one changed amino-acid-like part. Papers count the parts in different ways. This page uses the FDA record to keep the identity clear.
Type of peptide: Nerve-growth research compound. This describes what the substance is or how it works. It does not show that it is safe, effective, or approved.
What has been studied?
- Unclear: There is not enough reliable detail about the product or research to judge.
No P021 study in people was found in the searches completed on August 30, 2026.
Studies measured effects in mice, rats, or cells. They do not show what happens in people.
Animal findings cannot set a safe amount or show uncommon or long-term harms in people.
FDA identifies the chemical record. A product name alone does not show what is in the product or how it was made.
Products with the same ingredient can differ.
The ingredient name does not tell you everything about a product. Check its other ingredients, its form, how it enters the body, and the use and people covered by the research or approval.
None identified in the United States.
- No FDA-approved indication
Have a lab test report (COA) for a product sold under this name? Check what the report shows in 10 questions
Not sure if a product sold under this name is a prescription, compounded, or research-only vial? Sort it in 5 questions
What studies found
A 2010 mouse study reported changes in learning, memory, and the growth of new brain cells. Later mouse studies reported changes in memory, nerve-cell connections, tau, or amyloid. Tau and amyloid are proteins studied in Alzheimer’s disease. An aged-rat study measured lower tau after P021 treatment. A cell study and another mouse study had mixed results. None of these studies tested P21 in people.
No P021 study in people was found. The reviewed evidence does not show whether it improves memory, prevents dementia, or treats Alzheimer’s disease in people. It also does not establish a safe amount, long-term effects, or the quality of products sold with this name. Tests in human-derived cells happen in a lab. They are not studies in people.
Which products do these findings apply to?
FDA lists P-21, P021, and P21 under one chemical record. This record does not prove that a sold product contains the same compound used in a study. A name alone does not prove what is in a product or whether it was made safely.
Fact checks
6 statements checked. Read what the results mean.
“In FDA’s record, P21, P021, and P-21 are names for the same chemical record.”
Yes. FDA lists P21 and P021 as names for the P-21 chemical record. This name match does not prove that a sold product has the same contents or quality.
- What this answer is based on
- Official record or product label
- Limits of this answer
- The FDA chemical identity record; this does not establish drug approval, product quality, or human benefit.
Sources for this fact check (1)
“P21 improved learning and memory in mouse studies.”
Yes. Studies reported learning or memory findings in normal mice and in mouse models of Alzheimer-like disease. Results in mice do not prove a benefit in people.
- What this answer is based on
- Cell, animal, or other lab research
- Limits of this answer
- Normal adult mice and genetically changed mouse models; not people with memory problems or Alzheimer’s disease.
Sources for this fact check (3)
“P21 improves memory or treats Alzheimer’s disease in people.”
The reviewed studies used mice, rats, or cells. The P021 registry search found no study in people. Animal or cell findings cannot show that P21 treats people.
- What this answer is based on
- No reliable studies showing this health result in people
- Limits of this answer
- Memory or Alzheimer’s disease outcomes in people who received a verified P21 study product.
Sources for this fact check (5)
Show 3 more fact checks
“A P21 substance record means P21 is FDA-approved.”
FDA says a Unique Ingredient Identifier, or UNII, helps identify a substance. It does not mean that FDA reviewed or approved a drug. No FDA-approved P21 product was found under the reviewed names.
- What this answer is based on
- Official record or product label
- Limits of this answer
- United States drug-approval status as checked for P21, P021, and P-21 on August 30, 2026.
Sources for this fact check (2)
“P21 peptide is the same thing as the p21/CDKN1A protein.”
No. P21 peptide is a small compound made in a lab. CDKN1A is a human gene. It makes a protein also called p21. The shared short name does not make them the same.
- What this answer is based on
- Official record or product label
- Limits of this answer
- P21 peptide identity compared with the human CDKN1A gene and p21 protein.
Sources for this fact check (2)
“P21 has a proven safety profile in people.”
The P021 registry search found no study in people. Animal studies cannot set a safe amount, rule out uncommon harm, or show long-term safety for people.
- What this answer is based on
- No reliable studies showing this health result in people
- Limits of this answer
- People exposed to a verified P21 study product, with enough follow-up to assess harms.
Sources for this fact check (4)
Questions people ask about P21 peptide
No. P21 peptide is a small lab-made research compound. CDKN1A is a human gene that makes a protein also called p21. The shared short name does not make them the same.
Risks and safety limits
No reviewed study sets a safe amount or way to take P21. Long-term safety in people is also unknown. This guide gives no directions for use, buying advice, or treatment advice.
This editorial review did not determine sport eligibility. Athletes must check the current prohibited list, Global DRO, and their governing body.
Reviewed .Check the rules for athletes ↗Terms used in the studies
- peptide
- a short chain of amino acids
- mechanism
- how a substance may cause a body change
- biomarker
- a body or lab measurement, not automatically a health benefit
- preclinical
- research in cells, tissues, or animals before or outside testing in people
- outcome
- what the study measured
- amino acid
- a small building block that makes peptides and proteins
- indication
- the approved or studied use and patient group
Read the sources
Show 9 sources
Review history
Initial brief reviewed the FDA chemical record, primary animal and cell studies, the p21/CDKN1A name conflict, a ClinicalTrials.gov search for P021, and FDA drug-approval databases.
Not independently medically reviewed. This page is not a dosing, sourcing, or treatment guide.
Report a factual error